Positron emission tomography (PET) imaging with fluorodeoxyglucose (FDG) is a very
useful imaging modality that significantly contributes to the diagnosis and staging in patients …

T HE 1990s marked the emergence of positron emission tomography (PET) using F-18
fluorodeoxyglucose (FDG) as the single most powerful imaging tool in the diagnosis and …

Positron emission tomography (PET) with FDG has shown to be of substantial value in
differential diagnosis of pulmonary lesions and in the assessment of lymph node …

Lung cancer has graduated from merely a reportable disease of 1912 to being the most
common cause of cancer death in developed countries in recent years. The annual number …

Non-Small Cell Lung Cancer: FDG-PET Imaging Page 1 Journal of Thoracic lmaging 14:247–256
O 1999 Lippincott Williams & Wilkins. Inc. Philadelphia Non-Small Cell Lung Cancer: FDG-PET …

Positron-emission tomography (PET) with 18-fluorodeoxyglucose has a role in the diagnosis
and staging of lung cancer, but is also appealing for assessment of prognosis and treatment …

Lung cancer is the leading cause of cancer mortality among both males and females
throughout the world. Worldwide, as many as one million people are affected by the disease …

This communication presents an update on the current role of positron emission tomography-
computed tomography (PET-CT) in the various clinical decision-making steps in lung …

Lung cancer is the leading cause of death from cancer in both men and women. The
presence of distant metastases or metastases to mediastinal lymph nodes has a significant …

Positron emission tomography (PET) using [18F]-2-deoxy-2-fluoro-d-glucose (FDG) has
emerged as a valuable diagnostic modality in patients with non-small cell lung cancer …